![]() |
|
RESÚMENES JUNIO 2009 |
Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers
(Haga un click
en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
3! - Antidepressant-induced jitteriness/anxiety syndrome:
systematic review
Lindsey
I. Sinclair, David M. Christmas, Sean D. Hood, John P. Potokar,
Andrea Robertson, Andrew Isaac, Shrikant Srivastava, David J. Nutt, Simon J. C. Davies
The British
Journal of Psychiatry (2009) 194: 483-490
GRATIS 3! - Effect of a single dose of citalopram on amygdala response to emotional faces
Susannah E. Murphy, Raymond Norbury, Ursula O'Sullivan, Philip J. Cowen, Catherine J.
Harmer
The British Journal of
Psychiatry (2009) 194: 535-540
3 - Age at onset of first episode and time to treatment in in-patients with
bipolar disorder
Gunnar Morken,
Arne E. Vaaler, and Gunn E. Folden,
Ole A. Andreassen, Ulrik F.
Malt
The British Journal of
Psychiatry (2009) 194: 559-560
5< - Mirtazapine and paroxetine in
major depression: A comparison of monotherapy versus
their combination from treatment initiation
Pierre Blier,
Gabriella Gobbi, Julie E. Turcotte, Claude de Montigny, Nathalie Boucher,
Chantal Hébert and Guy Debonnel
European Neuropsychopharmacology. Volume
19, Issue 7, July 2009, Pages 457-465
4 - Pindolol
augmentation enhances response outcomes in first depressive episodes
Maria J. Portella,
Javier de Diego-Adeliño, Dolors Puigdemont, Rosario Pérez-Egea, Enric Álvarez,
Francesc Artigas and Víctor Pérez
European Neuropsychopharmacology. Volume 19, Issue 7, July 2009, Pages 516-519
3! - Pretreatment
regional brain glucose uptake in the midbrain on PET may predict remission from
a major depressive episode after three months of treatment
Matthew S. Milak,
Ramin V. Parsey, Leilani Lee, Maria A. Oquendo, Doreen M. Olvet, Francoise
Eipper, Kevin Malone and J. John Mann
Psychiatry Research: Neuroimaging. Volume 173, Issue 1, 15
July 2009, Pages 63-70
3! - Increased subgenual prefrontal cortex size in remitted patients with
major depressive disorder
Kaan Yucel,
Margaret McKinnon, Ramandeep Chahal, Valerie Taylor, Kathryn
Macdonald, Russell Joffe and Glenda MacQueen
Psychiatry Research: Neuroimaging. Volume 173, Issue 1, 15
July 2009, Pages 71-76
3! - Depressive
symptoms and metabolic risk: Effects of cortisol and
gender
Christoph Muhtz,
Birgit-Christiane Zyriax, Tilman Klähn, Eberhard
Windler and Christian Otte
Psychoneuroendocrinology. Volume 34, Issue 7, August 2009, Pages 1004-1011
3 - Selective changes in sensitivity to benzodiazepines,
and not other positive GABAA modulators, in rats receiving flunitrazepam chronically
Lisa R. Gerak
Psychopharmacology.
Volume 204, Number 4 / July, 2009: 667-677
3! - Major Depressive Disorder and
Hypothalamic-Pituitary-Adrenal Axis Activity. Results From a Large
Cohort Study
Sophie A. Vreeburg, Witte J. G. Hoogendijk,
Johannes van Pelt, Roel H. DeRijk,
Jolanda C. M. Verhagen,
Richard van Dyck, Johannes H. Smit,
Frans G. Zitman, MDBrenda W. J. H. Penninx
Arch
Gen Psychiatry. 2009;66(6):617-626
3! - Persisting Decline in Depression
Treatment After FDA Warnings
Anne M. Libby,
Heather D. Orton, Robert J. Valuck
Arch
Gen Psychiatry. 2009;66(6):633-639
GRATIS 3 - Epidemiologic heterogeneity of common mood and anxiety
disorders over the lifecourse in the general
population: a systematic review
Arijit Nandi, John R Beard
and Sandro
Galea
3 - Adverse
events with use of antiepileptic drugs: a prescription and event symmetry
analysis
Ioannis Tsiropoulos, Morten Andersen, Jesper Hallas
Pharmacoepidemiology
and Drug Safety. Volume 18 Issue
6, Pages 483 - 491
3 - An
increased risk of road traffic accidents after prescriptions of lithium or valproate?
Jørgen G. Bramness, Svetlana
Skurtveit, C. Ineke Neutel, Jørg Mørland,
Anders Engeland
Pharmacoepidemiology
and Drug Safety. Volume 18 Issue
6, Pages 492 - 496
3 - The history
of lithium therapy
Edward Shorter
Bipolar
Disorders. Volume 11 Issue
s2, Pages 4 - 9
3 - A critical
appraisal of lithium's efficacy and effectiveness: the last 60 years
Paul Grof and Bruno Müller-Oerlinghausen
Bipolar
Disorders. Volume 11 Issue
s2, Pages 10 - 19
3 -
Anticonvulsants in bipolar disorders: current research and practice and future
directions
Charles L Bowden
Bipolar
Disorders. Volume 11 Issue
s2, Pages 20 - 33
3 - Lithium
specificity in bipolar illness: a classic agent for the classic disorder
Samuel Gershon, KN
Roy Chengappa and Gin S Malhi
Bipolar
Disorders. Volume 11 Issue
s2, Pages 34 - 44
3 -
Antipsychotic agents in the treatment of bipolar mania
Mauricio Tohen and Eduard Vieta
Bipolar
Disorders. Volume 11 Issue
s2, Pages 45 - 54
3 - Medicating
mood with maintenance in mind: bipolar depression pharmacotherapy
Gin S Malhi, Danielle Adams and
Michael Berk
Bipolar
Disorders. Volume 11 Issue
s2, Pages 55 - 76
3 - Maintenance
treatment in bipolar disorder: a reassessment of lithium as the first choice
William Coryell
Bipolar
Disorders. Volume 11 Issue
s2, Pages 77 - 83
3 - The role of
lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis
Rodrigo Machado-Vieira, Husseini
K Manji and Carlos A Zarate Jr
Bipolar
Disorders. Volume 11 Issue
s2, Pages 92 - 109
3 -
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A
Systematic Review of the Literature
Benjamin I.
Goldstein, David E. Kemp, Joanna K. Soczynska, and
Roger S. McIntyre
J Clin
Psychiatry June 2, 2009: e1-e13
3 - Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
Alwan, Sura;
Friedman, Jan M
CNS
Drugs. 23(6):493-509, May 30, 2009
3 - Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder
Carter, Natalie J.;
McCormack, Paul L
CNS Drugs.
23(6):523-541, May 30, 2009
3! -
Mechanisms of gene–environment interactions in depression: evidence that genes
potentiate multiple sources of adversity
M. Wichers, D. Schrijvers,
N. Geschwind, N. Jacobs, I. Myin-Germeys,
E. Thiery, C. Derom, B.
Sabbe, F. Peeters, Ph. Delespaul and J.
van Os
Psychological
Medicine (2009), 39:1077-1086
3! -
Interaction between the 5-HTTLPR
serotonin transporter polymorphism and environmental adversity for mood and
anxiety psychopathology: evidence from a high-risk community sample of young
adults
Manfred Laucht, Jens Treutlein, Dorothea Blomeyer, Arlette F. Buchmann, Brigitte Schmid, Katja Becker, Ulrich S. Zimmermann, Martin H. Schmidt,
Günter Esser, Marcella Rietschel
and Tobias Banaschewski
The
International Journal of Neuropsychopharmacology,
Volume 12, Issue 06, July 2009, pp 737-747
5 - Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month
treatment of bipolar I depression
Eileen Brown, David L. Dunner, Susan L.
McElroy, Paul E. Keck, David H. Adams, Elisabeth Degenhardt, Mauricio Tohen and
John P. Houston
The
International Journal of Neuropsychopharmacology,
Volume 12, Issue 06, July 2009, pp 773-782
3 -
Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C
receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice
Eleonora Calcagno, Sara
Guzzetti, Alessandro Canetta, Claudia Fracasso, Silvio Caccia, Luigi Cervo and
Roberto W. Invernizzi
The
International Journal of Neuropsychopharmacology,
Volume 12, Issue 06, July 2009, pp 793-803
3! -
Common effects of lithium and valproate on
mitochondrial functions: protection against methamphetamine-induced
mitochondrial damage
Rosilla F. Bachmann, Yun
Wang, Peixiong Yuan, Rulun
Zhou, Xiaoxia Li, Salvatore Alesci,
Jing Du and Husseini K. Manji
The
International Journal of Neuropsychopharmacology,
Volume 12, Issue 06, July 2009, pp 805-822
3! - Relevance
of dorsal raphe nucleus firing in serotonin 5-HT2C
receptor blockade-induced augmentation of SSRIs
effects
Florence
Sotty, Joost H.A. Folgering, Lise T. Brennum, Sandra Hogg, Arne Mørk, Peter
Hertel and Thomas I.F.H. Cremers
Neuropharmacology. Volume 57, Issue 1, July 2009, Pages 18-24
3 -
Effects of the histone deacetylase
inhibitor sodium butyrate in models of depression and anxiety
Brigitta B. Gundersen and
Julie A. Blendy
Neuropharmacology. Volume 57, Issue 1, July 2009, Pages 67-74
3! -
Co-Treatment with Diazepam Prevents the Effects of Fluoxetine
on the Proliferation and Survival of Hippocampal
Dentate Granule Cells
Xuefei Wu and Eero Castrén
Biological Psychiatry. Volume 66, Issue 1, 1 July 2009, Pages 5-8
GRATIS 3! -
Management of obsessive-compulsive disorder with fluvoxamine
extended release
Lídia Ordacgi, Mauro V Mendlowicz, Leonardo F Fontenelle
Neuropsychiatric Disease
and Treatment. Published Date May 2009
4! -
Depressive relapse during lithium treatment associated with increased serum
thyroid-stimulating hormone: results from two placebo-controlled bipolar I
maintenance studies
M.
A. Frye, L. Yatham, T. A. Ketter,
J. Goldberg,
T. Suppes, J. R. Calabrese, C.
L. Bowden, E. Bourne,
R. S. Bahn, B. Adams
Acta Psychiatrica
Scandinavica.
Volume 120 Issue 1, Pages 10 - 13
3! - No
association of depression and anxiety with the metabolic syndrome: the
Norwegian HUNT study
B. Hildrum, A. Mykletun,
K. Midthjell, K. Ismail, A.
A. Dahl
Acta Psychiatrica
Scandinavica.
Volume 120 Issue 1, Pages 14 - 22
3! -
Association of depressive symptoms and metabolic syndrome in men
H. Viinamäki, T. Heiskanen,
S. M. Lehto, L. Niskanen,
H. Koivumaa-Honkanen, T. Tolmunen,
K. Honkalampi, T. Saharinen,
K. Haatainen, J. Hintikka
Acta Psychiatrica
Scandinavica.
Volume 120 Issue 1, Pages 23 - 29
3! -
Atypical depression is associated with suicide attempt in bipolar disorder
V. Sánchez-Gistau, F. Colom, A. Mané, S. Romero,
G. Sugranyes, E. Vieta
Acta Psychiatrica
Scandinavica.
Volume 120 Issue 1, Pages 30 - 36
3! -
Decrease in suicide among the individuals treated with antidepressants: a
controlled study of antidepressants in suicide, Sweden 1995–2005
G. Isacsson, A. Holmgren, U. Ösby, J. Ahlner
Acta Psychiatrica
Scandinavica.
Volume 120 Issue 1, Pages 37 - 44
3 - Brain-derived
neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression
RH Kang, HS Chang, ML Wong, MJ Choi,
JY Park, HY Lee, IK Jung, SH Joe, L Kim, SH Kim, YK Kim, CS Han, BJ Ham, HJ
Lee, YH Ko, MS Lee, and MS Lee
Journal
of Psychopharmacology First published on June 3, 2009
4 - Comparison
of Propofol and Thiopental as Anesthetic Agents for
Electroconvulsive Therapy: A Randomized, Blinded Comparison of Seizure
Duration, Stimulus Charge, Clinical Effect, and Cognitive Side Effects
Bauer, Jeanett; Hageman, Ida; Dam, Henrik;
Báez, Armando; Bolwig, Tom;
Roed, Jakob; Olsen, Niels Vidiendal; Jørgensen, Martin Balslev
The
Journal of ECT: June 2009 - Volume 25 - Issue 2 - pp 85-90
3 -
Differential Patterns of HPA Activity and Reactivity in Adult Posttraumatic
Stress Disorder and Major Depressive Disorder
Kathryn Handwerger
Harvard Review of
Psychiatry, Volume 17, Issue 3 June 2009, pages 184 - 205
3 - The
Bipolar Spectrum: A Critical Perspective
Joel Paris
Harvard
Review of Psychiatry, Volume 17, Issue 3 June 2009, pages 206 - 213
3! - Management
issues for women with epilepsy—Focus on pregnancy (an
evidence-based review): II. Teratogenesis and perinatal outcomes
Cynthia L. Harden, Kimford J. Meador,
Page B. Pennell, W. Allen Hauser, Gary S. Gronseth,
Jacqueline A. French, Samuel Wiebe, David Thurman,
Barbara S. Koppel, Peter W. Kaplan, Julian
N. Robinson, Jennifer Hopp, Tricia Y. Ting, Barry Gidal, Collin A. Hovinga, Andrew N. Wilner,
Blanca Vazquez, Lewis Holmes, Allan Krumholz,
Richard Finnell, Deborah Hirtz,
and Claire Le Guen
Epilepsia. Volume 50 Issue 5, Pages 1237 - 1246
3 - Genetic and pharmacokinetic factors affecting the
initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder
Yoshinori Saeki,
Takashi Watanabe, Mikito Ueda, Atsushi Saito,
Kazufumi Akiyama, Yoshimasa Inoue, Genta Hirokane,
Sachiyo Morita, Naoto Yamada and Kazutaka Shimoda
European Journal of Clinical Pharmacology. Volume 65, Number 7 / julio de 2009: 685-691
3 - Effect of smoking and CYP2D6 polymorphisms on the
extent of fluvoxamine–alprazolam
interaction in patients with psychosomatic disease
Hideyo Sugahara,
Chiharu Maebara, Hisakazu Ohtani, Masanori Handa,
Katsumi Ando, Kazunori Mine, Chiharu Kubo, Ichiro Ieiri and
Yasufumi Sawada
European Journal of Clinical Pharmacology. Volume 65, Number 7 / julio de 2009: 699-704
3! - Antidepressant use and mortality in Finland: a
register-linkage study from a nationwide cohort
Jari Haukka,
Martti Arffman, Timo Partonen, Sinikka Sihvo,
Marko Elovainio, Jari Tiihonen, Jouko Lönnqvist and
Ilmo Keskimäki
European Journal of Clinical Pharmacology. Volume 65, Number 7 / julio de 2009: 715-720
3 - The
Effect of Psychotherapy Added to Pharmacotherapy on Cortisol
Responses in Outpatients With Major Depressive
Disorder
Yang, Tsung-Tsair; Hsiao, Fei-Hsiu;
Wang, Kuo-Chang; Ng, Siu-Man;
Ho, Rainbow T. H; Chan, Cecilia L. W; Lai, Yu-Ming; Chen, Yu-Ting
The
Journal of Nervous and Mental Disease: June 2009 - Volume 197 - Issue 6 - pp
401-406
3 - The change in plasma GABA, glutamine and glutamate
levels in fluoxetine- or S-citalopram-treated
female patients with major depression
Esra Küçükibrahimoğlu,
Melek Z. Saygın, Mecit Çalışkan,
Okan K. Kaplan, Cüneyt Ünsal and M. Zafer Gören
European Journal of Clinical Pharmacology. Volume 65, Number 6 / junio de 2009: 571-577
3 - A proteomic investigation of similarities between
conventional and herbal antidepressant treatments
K Pennington, M Föcking, CA McManus, CM Pariante,
MJ Dunn, DR Cotter
Journal of Psychopharmacology, Vol. 23, No. 5, 520-530
(2009)
5< - Eight-week, placebo-controlled, double-blind
comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
K Hewett, W Chrzanowski, M Schmitz, A Savela,
V Milanova, M Gee, A Krishen,
L Millen, MO Leary, J Modell
Journal of Psychopharmacology, Vol. 23, No. 5, 531-538
(2009)
5 - Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis
IM Omori, N Watanabe, A Nakagawa, T Akechi, A Cipriani, C Barbui, H McGuire, R
Churchill, TA Furukawa
Journal of Psychopharmacology, Vol. 23, No. 5, 539-550
(2009)
3! - Normalisation of immune cell
imbalance after pharmacological treatments of patients suffering from
obsessive-compulsive disorder
D Marazziti,
F Mungai, I Masala, S Baroni, L Vivarelli, F Ambrogi,M Catena Dell’Osso, G
Consoli, G Massimetti, L Dell’Osso
Journal of Psychopharmacology, Vol. 23, No. 5, 567-573
(2009)
5 - Pharmacological interventions for the prevention of
relapse in bipolar disorder: a systematic review of controlled trials
S Beynon,
K Soares-Weiser, N Woolacott,
S Duffy, JR Geddes
Journal of Psychopharmacology, Vol. 23, No. 5, 574-591
(2009)
3! - Interaction Between
the Serotonin Transporter Gene (5-HTTLPR),
Stressful Life Events, and Risk of Depression. A Meta-analysis
Neil Risch,
Richard Herrell, Thomas Lehner,
Kung-Yee Liang, Lindon Eaves, Josephine Hoh, Andrea Griem, Maria Kovacs, Jurg Ott, Kathleen Ries Merikangas
3! - Cutaneous Adverse Reactions to Psychotropic Drugs: Data From a Multicenter Surveillance Program
Christian Lange-Asschenfeldt, Renate Grohmann,
Bernhard Lange-Asschenfeldt, Rolf R. Engel, Eckart Rüther, and Joachim Cordes
J Clin Psychiatry June 16, 2009: e1-e8
GRATIS 3 -
Persistence and compliance to antidepressant treatment in patients with
depression: A chart review
Norifusa
Sawada, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe,
Toshiaki Kikuchi, Takashi Handa
and Haruo Kashima
3 - A
multistage chronobiologic intervention for the
treatment of depression: A pilot study
Lucian Moscovici and Moshe Kotler
Journal of Affective
Disorders. Volume 116, Issue 3, August 2009, Pages 201-207
3! - Imipramine
Treatment and Resiliency Exhibit Similar Chromatin Regulation in the Mouse
Nucleus Accumbens in Depression Models
Matthew B. Wilkinson, Guanghua Xiao, Arvind Kumar,
Quincey LaPlant, William Renthal, Devanjan Sikder, Thomas J. Kodadek, and
Eric J. Nestler
The Journal of Neuroscience, June 17, 2009, 29(24):7820-7832
3 - Is it
always the same? Variability of depressive symptoms across six European
countries
Sebastian Bernert,
Herbert Matschinger, Jordi Alonso, Josep Maria Haro, Traolach S. Brugha,
Matthias C. Angermeyer and the ESEMeD / MHEDEA 2000 investigators
Psychiatry Research. Volume 168, Issue 2, 30
July 2009, Pages 137-144
3 - Neurobiology
of repeated transcranial magnetic stimulation in the
treatment of anxiety: a critical review
Pallanti, Stefano; Bernardi, Silvia
International
Clinical Psychopharmacology: July 2009 - Volume 24 - Issue 4 - pp 163-173
3! - The
efficacy of pregabalin and benzodiazepines in
generalized anxiety disorder presenting with high levels of insomnia
Montgomery, Stuart
A; Herman, Barry K; Schweizer, Edward; Mandel,
Francine S
International
Clinical Psychopharmacology: July 2009 - Volume 24 - Issue 4 - pp 214-222
3! -
Reducing Suicidal Ideation and Depression in Older Primary Care Patients:
24-Month Outcomes of the PROSPECT Study
George S. Alexopoulos,
Charles F. Reynolds III, Martha L. Bruce, Ira R. Katz, Patrick J. Raue, Benoit H. Mulsant, David W.
Oslin, Thomas Ten Have, and The PROSPECT Group
Am J Psychiatry Published June 15, 2009
3 - Influence of the novel antidepressant and melatonin
agonist/serotonin2C receptor antagonist, agomelatine,
on the rat sleep–wake cycle architecture
Amandine Descamps,
Colette Rousset, Mark Millan, Michael Spedding,
Philippe Delagrange and Raymond Cespuglio
Psychopharmacology. Volume 205, Number 1 /
julio de 2009: 93-106
3! - Antidepressant response to electroconvulsive therapy is sustained after
catecholamine depletion
Frederick Cassidy, Richard D. Weiner, Thomas B. Cooper and Bernard J.
Carroll
3! - Glutamate as a
spectroscopic marker of hippocampal structural
plasticity is elevated in long-term euthymic bipolar
patients on chronic lithium therapy and correlates inversely with diurnal cortisol
M Colla, F Schubert, M Bubner,
J O Heidenreich, M Bajbouj,
F Seifert, A Luborzewski,
I Heuser and G Kronenberg
Molecular
Psychiatry
(2009) 14, 696–704
3 - Regional distribution of clomipramine
and desmethylclomipramine in rat brain and peripheral
organs on chronic clomipramine administration
K Aitchison,
K Datla, H Rooprai, J
Fernando, and D Dexter
Journal of Psychopharmacology First
published on June 24, 2009
3! - Treatment
of depression in the elderly: A review of the recent literature on the efficacy
of single- versus dual-action antidepressants
Yuki Mukai and Rajesh R. Tampi
Clinical
Therapeutics. Volume 31, Issue 5, May 2009, Pages 945-961
3 -
Long-Term Safety and Efficacy of Ziprasidone in
Subpopulations of Patients With Bipolar Mania
Paul E. Keck, Jr; Marcio Versiani,
Lewis Warrington, Antony D. Loebel, and R. Lynn Horne
J
Clin Psychiatry 2009;70(6):844-851
3 - A
Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic
Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
Hisato Matsunaga,
Toshihiko Nagata, Kazuhisa Hayashida, Kenzo Ohya, Nobuo Kiriike, and Dan J. Stein
J Clin Psychiatry 2009;70(6):863-868
3 - The
Safety, Acceptability, and Effectiveness of Acupuncture as an Adjunctive
Treatment for Acute Symptoms in Bipolar Disorder
Ellen B. Dennehy, Rosa Schnyer, Ira H.
Bernstein, Robert Gonzalez, Geetha Shivakumar, Dorothy I. Kelly, Diane E. Snow, Suresh Sureddi, and Trisha Suppes
J Clin Psychiatry 2009;70(6):897-905
3 - Protein Kinase C Inhibitors: Rationale for Use and Potential in the
Treatment of Bipolar Disorder
Zarate,
Carlos A; Manji, Husseini K
CNS Drugs. 23(7):569-582, July 7, 2009
3 - Cardiovascular
Abnormalities in Patients with Major Depressive Disorder: Autonomic Mechanisms
and Implications for Treatment
Brown, Alex D.H; Barton, David A; Lambert, Gavin W
CNS Drugs. 23(7):583-602, July 7, 2009
5 - Relapse
rates with long-term antidepressant drug therapy: a meta-analysis
Nolan Williams, Annie N. Simpson, Kit Simpson, Ziad
Nahas
Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue
5, Pages 401 - 408
GRATIS 3! - Enhancement
of the function of rat serotonin and norepinephrine
neurons by sustained vagus nerve stimulation
Stella Manta, Jianming Dong, Guy Debonnel,
Pierre Blier
J Psychiatry Neurosci 2009;34(4):272-80
GRATIS 3! -
Estimating the Economic Costs of Antidepressant Discontinuation During Pregnancy
Lisa O’Brien, Audrey Laporte,
Gideon Koren
Can J Psychiatry. 2009;54(6):399–408
GRATIS 5 -
Extended Release Quetiapine Fumarate
Monotherapy for Major Depressive Disorder: Results of
a Double-Blind, Randomized, Placebo-Controlled Study
Richard Weisler, J. Mark Joyce, Lora McGill,
Arthur Lazarus, Johan Szamosi, and Hans Eriksson for
the Moonstone Study Group
CNS Spectr. 2009;14(6):299-313
GRATIS 4 - Escitalopram Versus SNRI
Antidepressants in the Acute Treatment of Major Depressive Disorder:
Integrative Analysis of Four Double-Blind, Randomized Clinical Trials
Susan G. Kornstein, Dayong
Li, Yongcai Mao, Sara Larsson, Henning F. Andersen,
and George I. Papakostas
CNS Spectr. 2009;14(6):326-333
GRATIS 3 (previo registro) - Selective
Serotonin Reuptake
Inhibitor Use During
Pregnancy
and Possible
Neonatal Complications
Current Psychiatry Reports 2009, 11: (3) 253-257
GRATIS 3 - Electroconvulsive therapy in major
depression: current aspects
ANTUNES, Paula
Barros et al.
Rev. Bras. Psiquiatr 2009, vol.31, suppl.1, pp. S26-S33
GRATIS 3 - Transcranial direct current stimulation: a promising alternative for the treatment of
major depression?
BERLIM, Marcelo T;
DIAS NETO, Vitor and TURECKI, Gustavo
Rev. Bras. Psiquiatr 2009, vol.31, suppl.1, pp. S34-S38
3 - Safety, tolerability and efficacy of a
rapid dose escalation of quetiapine in bipolar I
mania: the FATIMA study
Eric Constant, Arlette Seghers, Enio Ranalli, Vincent Ryckmans, Phillippe Snauwaert, Marcel Parent, Guy Vandenhoven
Acta Neuropsychiatrica. Volume 21 Issue
3, Pages 125 - 132
| Regresar a RESÚMENES JUNIO 2009 |